Rational Combinations of PARP Inhibitors with HRD-Inducing Molecularly Targeted Agents
Book chapter in Cancer Treatment and Research (November 2023)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib
Article in Cancers (August 2023)
Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
Article in eLife (April 2023)